Clinical Engineering Revisited: the Grip of Leadership-Part 2

摘要

A survey on two fundamental questions-Q_A: What is Clinical Engineering (CE)?, and Q_B: How can International Federation for Medical and Biological Engineering (IFMBE) with its partners advance CE globally?-was e-mailed to the Clinical Engineering Division of the IFMBE (CED/IFMBE) members at large. The survey actually consists of ten sub-questions Q_A1-Q_A5 and Q_B1-Q_B5-This work presents feedback of the CED/IFMBE leadership related to question Q_B. The survey response rate was 35% (18/51). The answer on question 'Q_B1: Do/can we legislate?' was 'Yes' in 9/17 (53%) cases, and 'No' in 8/17 (47%) cases. The answer on question 'Q_B2: Do we register?' was 'Yes' in 11/16 (69%) cases, 'No' in 4/16 (25%) cases, and ambiguous in 1/16 (6%) case. The answer on question 'Q_B3: Do we certify?' was 'Yes' in 15/17 (88%) cases, and 'No' in 2/17 (12%) cases. The answers on question Q_B4 were descriptive, and on question 'Q_B5: Do we support accredited CE Undergraduate programs?' were 'Yes' in 9/12 (75%) cases, and 'No' in 3/12 (25%) cases. Corresponding white paper of the CED/IFMBE is to be published.